Coherus Oncology (CHRS) Property, Plant & Equipment (Net) (QoQ) (2014 - 2026)

Coherus Oncology (CHRS) Property, Plant & Equipment (Net) (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Coherus Oncology 200.42 Mn 33.38 Mn 8.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.66%
Dec 31, 2025 -17.64%
Sep 30, 2025 -14.37%
Jun 30, 2025 -15.47%
Mar 31, 2025 -12.42%
Dec 31, 2024 -11.51%
Sep 30, 2024 -12.69%
Jun 30, 2024 -20.39%
Mar 31, 2024 -18.19%
Dec 31, 2023 -15.65%
Sep 30, 2023 -12.41%
Jun 30, 2023 -10.29%
Mar 31, 2023 -11.77%
Dec 31, 2022 -8.54%
Sep 30, 2022 0.19%
Jun 30, 2022 19.44%
Mar 31, 2022 2.37%
Dec 31, 2021 -8.14%
Sep 30, 2021 -6.85%
Jun 30, 2021 -5.58%